Tag #Sackler Family

Showing 1 to 6 of 6 results

abcnews.go.com

🌐 85% Global Worthiness

Mar 19, 10:16

Purdue Pharma Offers $7 Billion Opioid Settlement, Sackler Family to Relinquish Ownership

Purdue Pharma proposes a $7 billion settlement to resolve OxyContin lawsuits, with the Sackler family relinquishing ownership and contributing funds over 15 years, addressing past concerns by allowing plaintiffs to opt-in to the deal and potentially receive more than $850 million.

Purdue Pharma Offers $7 Billion Opioid Settlement, Sackler Family to Relinquish Ownership

Purdue Pharma proposes a $7 billion settlement to resolve OxyContin lawsuits, with the Sackler family relinquishing ownership and contributing funds over 15 years, addressing past concerns by allowing plaintiffs to opt-in to the deal and potentially receive more than $850 million.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this settlement compare to other opioid lawsuit settlements, and what factors contributed to its structure?

This settlement connects to a broader pattern of opioid litigation against pharmaceutical companies. The Sacklers' contribution, exceeding $1 billion more than previous offers, attempts to address criticisms of insufficient accountability. The deal's structure, requiring plaintiff opt-in, reflects a compromise balancing the needs of victims and the Sacklers' liability.

aljazeera.com

🌐 90% Global Worthiness

Jan 24, 01:09

\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits

Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...

\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits

Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the total amount of the settlement, and how does it compare to previous attempts, and what are the immediate implications?

Purdue Pharma and the Sackler family will pay up to \$7.4 billion to settle lawsuits related to the opioid crisis caused by OxyContin. This is \$1 billion more than a previous rejected settlement. The Sacklers will pay up to \$6.5 billion, and Purdue will contribute \$900 million.

apnews.com

🌐 90% Global Worthiness

Jan 23, 22:08

Sackler Family Agrees to $7.4 Billion Opioid Settlement

The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.

Sackler Family Agrees to $7.4 Billion Opioid Settlement

The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the $7.4 billion settlement on the opioid crisis?

The Sackler family, owners of Purdue Pharma (OxyContin's maker), agreed to a $7.4 billion settlement to resolve lawsuits stemming from the opioid crisis. This includes a $6.5 billion payment from the Sacklers and nearly $900 million from Purdue. The settlement surpasses a previous deal, adding $500 million more from the family.

us.cnn.com

🌐 85% Global Worthiness

Mar 19, 16:10

Purdue Pharma's Revised \$7.4 Billion Opioid Settlement Plan Filed

Purdue Pharma filed a new \$7.4 billion bankruptcy plan to settle opioid lawsuits, addressing Supreme Court concerns by offering creditors a choice to participate and increasing Sackler family contributions to between \$6.5 and \$7 billion, with \$850 million for individuals harmed.

Purdue Pharma's Revised \$7.4 Billion Opioid Settlement Plan Filed

Purdue Pharma filed a new \$7.4 billion bankruptcy plan to settle opioid lawsuits, addressing Supreme Court concerns by offering creditors a choice to participate and increasing Sackler family contributions to between \$6.5 and \$7 billion, with \$850 million for individuals harmed.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the new plan address the Supreme Court's concerns regarding the scope of the previous settlement?

This revised plan addresses the Supreme Court's rejection of the previous settlement by offering creditors the option to participate. Those opting out can pursue separate lawsuits against the Sacklers. The increased financial contribution from the Sacklers (\$1 billion more than the previous offer) reflects the court's concerns regarding their liability.

kathimerini.gr

🌐 85% Global Worthiness

Jan 24, 01:09

Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement

Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...

Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement

Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors contributed to the Supreme Court's rejection of the previous 2022 settlement?

This settlement resolves claims against Purdue Pharma and the Sackler family for aggressively marketing OxyContin, a highly addictive painkiller, despite knowing its risks. The settlement comes after years of litigation and reflects the significant human and economic costs of the opioid crisis in the US, where over 700,000 deaths have been linked to opioid overdoses since 1999.

cnn.com

🌐 85% Global Worthiness

Jan 23, 22:08

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion

Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion

Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What role did the Supreme Court play in shaping this settlement?

The $7.4 billion settlement resolves lawsuits alleging deceptive marketing of OxyContin, contributing to the opioid crisis and over 700,000 overdose deaths. The Sacklers, while denying wrongdoing, expressed regret. This is part of a broader trend of opioid manufacturers facing massive payouts.

Showing 1 to 6 of 6 results